Biosig to present at noblecon18 capital markets conference

Westport, ct, april 07, 2022 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that kenneth l. londoner, chairman and ceo of biosig technologies, will be presenting at noblecon18 - noble capital markets' eighteenth annual investor conference at the hard rock hotel & casino, hollywood, florida on wednesday, april 20, 2022 at 9:30 am et. conference attendees will also have the opportuntity to meet biosig management during breakout sessions scheduled for 1:00 pm et on wednesday april 20, 2022.
BSGM Ratings Summary
BSGM Quant Ranking